Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction
- 24 April 2006
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 194 (5), 1347-1353
- https://doi.org/10.1016/j.ajog.2005.11.018
Abstract
No abstract availableKeywords
Funding Information
- Ministero della Salute
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Sixth Framework Programme (LSHM-CT-2004-512040)
- Istituto Superiore di Sanità
This publication has 25 references indexed in Scilit:
- Pentraxin 3 Inhibits Fibroblast Growth Factor 2–Dependent Activation of Smooth Muscle Cells In Vitro and Neointima Formation In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- PENTRAXINS AT THE CROSSROADS BETWEEN INNATE IMMUNITY, INFLAMMATION, MATRIX DEPOSITION, AND FEMALE FERTILITYAnnual Review of Immunology, 2005
- Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studiesBMJ, 2005
- Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial InfarctionCirculation, 2004
- Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cellsAtherosclerosis, 2004
- Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesisBlood, 2004
- Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune responseNature, 2002
- Placental-fetal Interrelationship in IUGR Fetuses—A ReviewPlacenta, 2002
- A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre‐eclamptic pregnanciesBJOG: An International Journal of Obstetrics and Gynaecology, 1994
- Fitting growth curves to head and abdomen measurements of the fetus: A multicentric studyJournal of Clinical Ultrasound, 1987